| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ETTX | Entasis Therapeutics Holdings Inc. | Innoviva, Inc. | 10% Owner | Jul 08, 2022 | Buy | $2.20 | 11,671,662 | 25,677,657 | 21,671,662 | Jul 13, 2022, 09:27 PM | |
| ETTX | Entasis Therapeutics Holdings Inc. | Innoviva, Inc. | 10% Owner | Jul 11, 2022 | Buy | $2.20 | 7,598,814 | 16,717,391 | 29,270,476 | Jul 13, 2022, 09:27 PM | |
| ARMP | Armata Pharmaceuticals, Inc. | Innoviva, Inc. | Director | Mar 31, 2022 | Buy | $5.00 | 5,385,208 | 26,926,040 | 16,365,969 | Apr 01, 2022, 04:52 PM | |
| ARMP | Armata Pharmaceuticals, Inc. | Innoviva, Inc. | Director | Feb 09, 2022 | Buy | $5.00 | 3,614,792 | 18,073,960 | 10,980,761 | Feb 11, 2022, 06:56 PM | |
| ARMP | Armata Pharmaceuticals, Inc. | Innoviva, Inc. | Director | Oct 29, 2021 | Buy | $3.30 | 1,212,122 | 4,000,003 | 7,365,969 | Nov 01, 2021, 02:20 PM | |
| ARMP | Armata Pharmaceuticals, Inc. | Innoviva, Inc. | Director | Mar 17, 2021 | Buy | $3.25 | 4,285,935 | 13,929,289 | 6,153,847 | Mar 17, 2021, 05:16 PM | |
| ARMP | Armata Pharmaceuticals, Inc. | Innoviva, Inc. | Director | Jan 26, 2021 | Buy | $3.25 | 1,867,912 | 6,070,714 | 1,867,912 | Jan 28, 2021, 01:43 PM | |
| ETTX | Entasis Therapeutics Holdings Inc. | Innoviva, Inc. | 10% Owner | Sep 01, 2020 | Buy | $2.67 | 4,672,897 | 12,499,999 | 18,672,897 | Sep 01, 2020, 05:31 PM | |
| ETTX | Entasis Therapeutics Holdings Inc. | Innoviva, Inc. | 10% Owner | Jun 11, 2020 | Buy | $2.50 | 12,677,490 | 31,693,725 | 14,000,000 | Jun 12, 2020, 05:34 PM | |
| ARMP | Armata Pharmaceuticals, Inc. | Innoviva, Inc. | 10% Owner | Mar 27, 2020 | Buy | $2.87 | 7,717,661 | 22,149,686 | 8,710,800 | Mar 31, 2020, 04:54 PM |
Menu